v" Meningiomas have been shown to have steroid-binding proteins. In vitro, estradiol, progesterone, and the antiestrogen tamoxifen stimulate tumor growth. However, incubation of tumor cells with an antiprogesterone agent results in tumor inhibition. In this investigation, a human meningioma was implanted subcutaneously in athymic nude mice. Two treatment groups were established, one receiving the antiprogesterone agent RU-38486 (10 mg/kg/day in suspension) and the other receiving only vehicle. After 3 months, the tumor growth index (defined as the tumor volume at 3 months divided by the initial tumor volume) was 0.25 _+ 0.46 (mean + standard deviation) in the group receiving antiprogesterone and was 1.54 + 0.58 in the control group (p = 0.041). Further investigation of the effect of antiprogestational agents on the growth and hormone-binding proteins of other meningiomas will better define the mechanism of their effects. KEY WORDS 9 meningioma 9 antiprogesterone 9 tumor growth index 9 nude mice
I
t is well established that meningiomas contain steroid-binding proteins. 4,s' 8,2~ Subsequent investigation has shown that progesterone, estradiol, and the antiestrogen tamoxifen modulate growth of meningioma cells in vitro. I~'~9 Further evidence that these tumors are hormone-responsive has been deduced from the predominance of the tumor in females and the observation that the tumors may cause symptoms during pregnancy that resolve after delivery. 2"6'7'1~ 13.22.23,29 In previous work, it has been demonstrated that there are high concentrations of progesterone-binding protein present in meningioma tissue and that the antiprogesterone agent RU-38486 decreased growth of meningioma cells in tissue culture. ~9 In this report, these studies have been expanded to examine the effect of this antiprogestational agent on the growth of meningioma tissue implanted into nude mice.
Materials and Methods
A freshly resected human meningioma was divided into three portions: one for histological study, one for binding assays, and the third for implantation in athymic nude mice.* For histological evaluation, the * Mice obtained from Harlan Sprague Dawley, Inc., Indianapolis, Indiana.
tissue was paraffin-embedded, stained with hematoxylin and eosin, and studied by light microscopy.
For estrogen receptor determinations, cytosol was incubated with 1 nM tritiated (3H) estradiol (10l Ci/ mM) and with increasing concentrations of unlabeled estradiol (0 to 500 pg/tube) at 4~ for 18 hours.? Progesterone receptor determinations were made by incubation of cytosol with 1 nM 3H Promegestone (87 Ci/mM) and with increasing concentrations of unlabeled progesterone (0 to 1000 pg/tube) at 4~ for 4 hours.~ Bound and free hormones were separated by dextran-coated charcoal, and radioactivity was determined in a liquid scintillation counter.w Receptor concentration and binding affinity were determined by Scatchard analyses] 4
The tumor to be implanted into the mice was divided into six equal fragments each measuring 3 x 3 x 4 ram. Six male athymic, nu/nu Balb C mice, each weighing 35 to 45 rag, were anesthetized with intraperitoneal chloral hydrate. After the region was prepared with 70% ethyl alcohol, a 5-to 6-ram incision was made over the 
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volume of the suspension vehicle orally on a daily basis. The animals were kept in standard filtered-air hoods and fed clean food and water ad libitum. At the end of 3 months, the animals were sacrificed and autopsied; the tumor nodules were fixed in formalin for histological evaluation. Comparative t u m o r growth was determined by a growth index (GI) calculated such that GI = Vf/Vi, where Vf represented nodule volume after 3 months of drug treatment and Vi represented nodule volume measured 1 week after implantation. The results were compared using Student's t-test for unpaired data.
Results
Histological evaluation of the original neoplasm revealed primarily meningothelial components with little fibrous tissue (Fig. 1 left) . The concentrations of specific estrogen-binding and progesterone-binding protein in the original t u m o r were 3.99 fM/mg cytosol protein and 89.4 fM/mg cytosol protein, respectively. The growth data are summarized in Table 1 . The average growth index for the control group was significantly higher than for the group receiving RU-38486. Light microscopic evaluation of t u m o r nodules in the control animals showed a core of meningothelial cells in the nodule of each animal (Fig. 1 right) . A small number of cells resembling those of the primary tumor were found in one mouse of the experimental group, but only scar tissue was present in the other two experimental mice. The nodules in two of the three experimental mice disappeared within 8 to 10 weeks of treatment. Over the 3-month period, no overtly deterimental effects on body habitus, feeding, or growth were noted in either group.
Discussion
Recurrent meningiomas are usually treated by reoperation or by radiation therapy. 1,~4-~6,~8,26 Unfortunately, these tumors are not clearly radiosensitive, and reoperation can be fraught with complications. 4,9,~7,26,3~ The development of a hormonal agent that could decrease tumor size in patients with recurrent meningioma would be a major therapeutic advance.
Meningiomas have been shown to contain specific binding proteins for estrogen and progesterone, raising the possibility that these tumors might respond to hormonal manipulation.4'5'8"2~ Jay, et al.,~ ~ showed in vitro growth stimulation with estradiol, progesterone, and the antiestrogen tamoxifen. Although lower concentrations of binding protein were measured, these results have been confirmed in a separate investigation in addition to demonstrating that the antiprogestational agent RU-38486 inhibits the growth of cell populations in vitro. 19 This study suggests that this antiprogestational compound may be efficacious in decreasing tumor size and may potentially be important in the treatment of recurrent meningioma.
The growth and study of other tumors, such as bladder carcinoma and glioblioblastoma, in nude mice are well accepted. 3,27 This technique offers a physiological milieu for the long-term maintenance of tumor cell lines. Nevertheless, the physiological and immunological parameters present in the subcutaneous tissue of a nude mouse are quite different from those in the human cranial vault. The effects on hormone-binding proteins, tumor growth rate, and physiological response to hormonal manipulation in mice may not parallel the tumor response in humans, and these results must be interpreted in light of these factors. Although these are preliminary data, our findings justify a larger in vivo study of the effect of antiprogestational agents on the growth of meningiomas as well as an investigation of the effects of the antiprogestational agent on hormonebinding proteins in these tissues. These proposals are aimed at defining possible alternative methods of therapy for meningiomas.
